Featured series 
Tag: DARPA
-
Nation & World
Wyss Institute to accelerate drug testing for COVID treatment
With a $16 million agreement from DARPA, Harvard’s Wyss Institute will use its technology to identify and test already FDA-approved drugs that may prevent or treat COVID-19 infection.
-
Nation & World
Robots, exoskeletons, and invisible planes
The Defense Advanced Research Projects Agency, or DARPA, is the rare government agency that is all about change, in this case endlessly improving technology that has military applications.
-
Nation & World
The $3 million suit
The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded a first-phase, follow-on contract from the Defense Advanced Research Projects Agency to further develop its Soft Exosuit ― a wearable robot — alternative versions of which could eventually help those with limited mobility as well.
-
Nation & World
Technically, you are what you wear
The Google Glass and Warrior Web projects highlight the annual Radcliffe Science Symposium, which focused on the integration of technology with “smart clothes.”
-
Nation & World
Robots to the rescue
The Second Annual Northeast Robotics Colloquium highlighted Harvard’s work on the next generation of robotics.
-
Nation & World
Smart suit improves physical endurance
Harvard’s Wyss Institute for Biologically Inspired Engineering announced that it has received a $2.6 million contract from the Defense Advanced Research Projects Agency (DARPA) to develop a smart suit that helps improve physical endurance for soldiers in the field.
-
Nation & World
Soft-bots
Harvard Professor George Whitesides and his research team have developed an array of “soft” robots based on natural forms, including squids and starfish, that may one day be used to aid disaster recovery efforts by squeezing into the rubble left by an earthquake to locate survivors, or as a way to free up a surgeon’s…
-
Nation & World
Wyss Institute project targets sepsis
The Wyss Institute for Biologically Inspired Engineering at Harvard has been awarded a $12.3 million, four-year grant from the Defense Advanced Research Projects Agency to develop a treatment for sepsis, a commonly fatal bloodstream infection.
